Quantitative and qualitative adaptations of muscle fibers to glucocorticoids

Muscle and Nerve

Volumn 52, Issue 4, 2015, Pages 631-639

  Minetto, Marco Alessandro ^a   Qaisar, Rizwan ^b   Agoni, Valentina ^b   Motta, Giovanna ^a   Longa, Emanuela ^b   Miotti, Danilo ^c   Pellegrino, Maria Antonietta ^b   Bottinelli, Roberto ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IRCCS   (Italy)

Author keywords

Cross sectional area; Maximal shortening velocity; Myosin; Specific force; Steroid myopathy

Indexed keywords

ATROGIN 1; DEXAMETHASONE; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; MYOSIN HEAVY CHAIN; MYOSTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; CREATINE KINASE; GLUCOCORTICOID; HYDROCORTISONE; MYOSIN;

ADAPTATION; ADULT; ARTICLE; DRUG EFFECT; FAST MUSCLE FIBER; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; KNEE FUNCTION; LABORATORY TEST; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE STRENGTH; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TORQUE; VASTUS LATERALIS MUSCLE; BLOOD; CLASSIFICATION; DIET RESTRICTION; DRUG EFFECTS; GENETICS; INNERVATION; KNEE; METABOLISM; NONPARAMETRIC TEST; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ADULT; CREATINE KINASE; DEXAMETHASONE; FASTING; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; KNEE; MALE; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MYOSINS; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TORQUE;

EID: 84942195878     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24572     Document Type: Article

References (48)

1. Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, D'Antona G. Steroid myopathy: some unresolved issues. J Endocrinol Invest 2011;34:370-375.
2. Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol 2013;45:2163-2172.
3. van der Hoeven JH. Decline of muscle fiber conduction velocity during short-term high-dose methylprednisolone therapy. Muscle Nerve 1996;19:100-102.
4. Minetto MA, Botter A, Lanfranco F, Baldi M, Ghigo E, Arvat E. Muscle fiber conduction slowing and decreased levels of circulating muscle proteins after short-term dexamethasone administration in healthy subjects. J Clin Endocrinol Metab 2010;95:1663-1671.
5. Gruener R, Stern LZ. Corticosteroids. Effects on muscle membrane excitability. Arch Neurol 1972;26:181-185.
6. Dlouhá H, Vyskocil F. The effect of cortisol on the excitability of the rat muscle fiber membrane and neuromuscular transmission. Physiol Bohemoslov 1979;28:485-494.
7. Ruff RL, Martyn D, Gordon AM. Glucocorticoid-induced atrophy is not due to impaired excitability of rat muscle. Am J Physiol 1982;243:E512-521.
8. Ruff RL, Stühmer W, Almers W. Effect of glucocorticoid treatment on the excitability of rat skeletal muscle. Pflugers Arch 1982;395:132-137.
9. D'Antona G, Pellegrino MA, Adami R, Rossi R, Carlizzi CN, Canepari M, et al. The effect of ageing and immobilization on structure and function of human skeletal muscle fibers. J Physiol 2003;552:499-511.
10. Canepari M, Pellegrino MA, D'Antona G, Bottinelli R. Single muscle fiber properties in aging and disuse. Scand J Med Sci Sports 2010;20:10-19.
11. Borina E, Pellegrino MA, D'Antona G, Bottinelli R. Myosin and actin content of human skeletal muscle fibers following 35 days bed rest. Scand J Med Sci Sports 2010;20:65-73.
12. Baudry S, Lanfranco F, Merletti R, Duchateau J, Minetto MA. Effects of short-term dexamethasone administration on corticospinal excitability. Med Sci Sports Exerc 2014;46:695-701.
13. Khaleeli AA, Edwards RH, Gohil K, McPhail G, Rennie MJ, Round J, et al. Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) 1983;18:155-166.
14. Bottinelli R, Canepari M, Pellegrino MA, Reggiani C. Force-velocity properties of human skeletal muscle fibers: myosin heavy chain isoform and temperature dependence. J Physiol 1996;495:573-586.
15. Bottinelli R, Betto R, Schiaffino S, Reggiani C. Unloaded shortening velocity and myosin heavy chain and alkali light chain isoform composition in rat skeletal muscle fibers. J Physiol 1994;478:341-349.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
17. Brenner B. Technique for stabilizing the striation pattern in maximally calcium-activated skinned rabbit psoas fibers. Biophys J 1983;41:99-102.
18. Bottinelli R, Schiaffino S, Reggiani C. Force-velocity relations and myosin heavy chain isoform compositions of skinned fibers from rat skeletal muscle. J Physiol 1991;437:655-672.
19. Pellegrino MA, Canepari M, Rossi R, D'Antona G, Reggiani C, Bottinelli R. Orthologous myosin isoforms and scaling of shortening velocity with body size in mouse, rat, rabbit and human muscles. J Physiol 2003;546:677-689.
20. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-1708.
21. Welch BL. The generalisation of student's problems when several different population variances are involved. Biometrika 1947;34:28-35.
22. Leppert W, Buss T. The role of corticosteroids in the treatment of pain in cancer patients. Curr Pain Headache Rep 2012;16:307-313.
23. Gaujoux-Viala C, Gossec L. When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations. Ann NY Acad Sci 2014;1318:32-40.
24. Woods JA, Wheeler JS, Finch CK, Pinner NA. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:421-430.
25. Ordway GA, Garry DJ. Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol 2004;207:3441-3446.
26. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH Jr, et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 2001;280:E221-228.
27. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 2000;275:40235-40243.
28. Gilson H, Schakman O, Combaret L, Lause P, Grobet L, Attaix D, et al. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 2007;148:452-460.
29. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 2003;285:E363-371.
30. Inder WJ, Jang C, Obeyesekere VR, Alford FP. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1-implications for steroid-induced myopathy. Clin Endocrinol (Oxf) 2010;73:126-132.
31. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003;24:78-90.
32. Leick L, Fentz J, Biensø RS, Knudsen JG, Jeppesen J, Kiens B, et al. PGC-1α is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2010;299:E456-465.
33. Milani P, Piu P, Popa T, della Volpe R, Bonifazi M, Rossi A, et al. Cortisol-induced effects on human cortical excitability. Brain Stimul 2010;3:131-139.
34. Peter JB, Verhaag DA, Worsfold M. Studies of steroid myopathy. Examination of the possible effect of triamcinolone on mitochondria and sarcotubular vesicles of rat skeletal muscle. Biochem Pharmacol 1970;19:1627-1636.
35. Metzinger L, Passaquin AC, Leijendekker WJ, Poindron P, Rüegg UT. Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol 1995;116:2811-2816.
36. Narayanan N, Yang C, Xu A. Dexamethasone treatment improves sarcoplasmic reticulum function and contractile performance in aged myocardium. Mol Cell Biochem 2004;266:31-36.
37. Rao MK, Xu A, Narayanan N. Glucocorticoid modulation of protein phosphorylation and sarcoplasmic reticulum function in rat myocardium. Am J Physiol Heart Circ Physiol 2001;281:H325-333.
38. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 2007;6:376-385.
39. Degens H, Larsson L. Application of skinned single muscle fibres to determine myofilament function in ageing and disease. J Musculoskel Neuron Interact 2007;7:56-61.
40. Widrick JJ, Knuth ST, Norenberg KM, Romatowski JG, Bain JL, Riley DA, et al. Effect of a 17 day spaceflight on contractile properties of human soleus muscle fibres. J Physiol 1999;516:915-930.
41. Larsson L, Li X, Yu F, Degens H. Age-related changes in contractile properties and expression of myosin isoforms in single skeletal muscle cells. Muscle Nerve 1997;5(suppl):74-78.
42. Riley DA, Bain JL, Romatowski JG, Fitts RH. Skeletal muscle fiber atrophy: altered thin filament density changes slow fiber force and shortening velocity. Am J Physiol Cell Physiol 2005;288:C360-365.
43. Riley DA, Bain JL, Thompson JL, Fitts RH, Widrick JJ, Trappe SW, et al. Decreased thin filament density and length in human atrophic soleus muscle fibers after spaceflight. J Appl Physiol (1985) 2000;88:567-572.
44. Höök P, Sriramoju V, Larsson L. Effects of aging on actin sliding speed on myosin from single skeletal muscle cells of mice, rats, and humans. Am J Physiol Cell Physiol 2001;280:C782-788.
45. Ramamurthy B, Höök P, Jones AD, Larsson L. Changes in myosin structure and function in response to glycation. FASEB J 2001;15:2415-2422.
46. Hanson P, Dive A, Brucher JM, Bisteau M, Dangoisse M, Deltombe T. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997;20:1371-1380.
47. Stehle R, Brenner B. Cross-bridge attachment during high-speed active shortening of skinned fibers of the rabbit psoas muscle: implications for cross-bridge action during maximum velocity of filament sliding. Biophys J 2000;78:1458-1473.
48. 2+ channel function in an acute septic myopathy model. J Neurol 2010;257:546-555.